Bank Julius Baer & Co
ONCY

Bank Julius Baer & Co’s Oncolytics Biotech ONCY Stock Holding History

Bank Julius Baer & Co’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-750
Closed -$1K – 836
2020
Q3 		$1K Hold
750
– – ﹤0.01% 729
2020
Q2 		$1K Buy
750
+32
+4% +$60 ﹤0.01% 676
2020
Q1 		$1K Buy
+718
New +$1.79K ﹤0.01% 630

Other funds holding ONCY

Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank Julius Baer & Co's ONCY Position: Q4 2020 in Review

Bank Julius Baer & Co sold out of Oncolytics Biotech (ONCY) in Q4 2020, closing a stake of 750 shares — an estimated $1K sold.

Bank Julius Baer & Co first reported a position in ONCY in Q1 2020 and held it in 3 quarters. The position peaked at $1K in Q3 2020. 36 funds tracked by Wall St. Rank hold ONCY as of Q4 2020.

  • Bank Julius Baer & Co reported no remaining Oncolytics Biotech position as of Q4 2020 after selling out during the quarter.
  • Bank Julius Baer & Co sold 750 Oncolytics Biotech shares in Q4 2020, an estimated $1K.
  • Bank Julius Baer & Co first reported a position in Oncolytics Biotech in Q1 2020 and held it in 3 quarters.
  • Bank Julius Baer & Co's Oncolytics Biotech position peaked at $1K in Q3 2020.
  • 36 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q4 2020.

Based on Bank Julius Baer & Co's 13F filing for Q4 2020, filed 12 Feb 2021.